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Objectives: To explore the feasibility of delivering and evaluating a web-based walking 
intervention for people with long term musculoskeletal conditions (LTMCs), to determine its 
acceptability and the feasibility of conducting a definitive trial. 
 
Design: Prospective randomised feasibility study, with blind outcome assessment at 
baseline, 3 and 6 months.  
 
Setting: Hospital based physiotherapy service. 
 
Participants: 41 adults referred for assessment and advice for any mild/moderate LTMCs. 
doing < 120 mins of moderate intensity activity per week. 
 
Interventions: Participants randomised to  
1. Usual care: One usual physiotherapy advice and assessment session, including 
setting a physical activity goal and one follow up session (8 weeks). 
2.  “Walk30X5”: Session one, usual care plus intervention of walking programme. 
Participants were shown the website and podcasts and practiced how to use them. One 
follow up session (8 weeks). 
 
Outcome measures: Primary: timed six minute walk test (T6MWT). Secondary: step count, 
self-reported pain, fatigue, mood, self-efficacy, happiness, objective blood pressure, peak 
expiratory flow rate, and self-report and accelerometer measured physical activity. 
Results: Recruitment target achieved. No adverse events occurred. Adherence was high and 
the intervention acceptable. Loss to follow up n=3 (7%) at 3 months, n=8 (20%) at 6 months. 
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T6MWT and step count proved suitable outcomes, unlike accelerometry. Estimated sample 
size for a definitive trial is 216.  
 
Conclusions: “Walk30X5” is ready for evaluation in a future, appropriately powered (n=216), 
phase III trial. If effective, the intervention will provide a cheap, highly accessible  
intervention to enable people with mild/moderate LTMCs to achieve UK physical activity 
guidelines. 
Clinical Trial Registration Number: ISRCTN78581097 
 
Keywords: Musculoskeletal conditions, physical activity, walking programme, feasibility 
study, web-based intervention 
 
INTRODUCTION 
Physical inactivity is a major global healthcare issue, responsible for 13·4 million disability-
adjusted life-years worldwide and costing health-care systems at least 53.8 billion 
international $ in 20131. There is irrefutable evidence of health and psychological benefits 
from physical activity for both healthy adults and those with disabilities and/or obesity2. 
Current guidance in the United Kingdom (UK) recommends adults undertake  a minimum of 
150 minutes (2½ hours) of moderate intensity activity, in bouts of 10 minutes or more, each 
week or 75 minutes of vigorous intensity activity spread across the week or combinations of 
moderate and vigorous intensity activity2. In addition they should undertake at least two 
sessions of muscle strength training, each week2.  
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Musculoskeletal conditions account for the largest cause of disability, and the largest 
proportion of years lived with a disability in the UK, adversely impacting upon activities of 
daily living and living independently, in addition to causing symptoms such as pain3. Over 
ten million people in the UK live with long-term musculoskeletal conditions (LTMCs). LTMCs 
account for 7.5 million days off work and, with indirect costs, cost the UK £24.8 billion for 
back pain, osteoarthritis and rheumatoid arthritis combined each year3. The majority of 
people with musculoskeletal conditions do not meet physical activity (PA) guidelines and 
consequently have an increased risk of co-morbidity than their peers4-6. The benefits of PA 
are well demonstrated in the primary and secondary prevention of prevalent chronic 
diseases and premature death7-8. Walking, even at short duration or low volumes, can 
reduce risk for all-cause mortality and increase health-related fitness9-10. Walking is a 
popular11, accessible form of PA, across all age ranges that can substantially lower the risk of 
many chronic diseases11-12 and benefits mental health13. A systematic review of walking 
interventions in people with chronic musculoskeletal pain indicates walking is associated 
with significant improvements in pain and self-reported function14. However most (19/26) 
studies involved supervised walking (clinic, hospital, gym) which is considered unfeasible for 
physiotherapy services in the National Health Service (NHS)15 to implement and generally 
the long-term effectiveness of these interventions remains unknown.  
 
Web-based interventions for chronic pain result in small pain reductions, potentially helping 
people by decreasing treatment costs and side effects16.  Web-based programmes to 
increase PA have been popular in the general population, for example the ‘Couch to 5K’ 
running programme, but there have been no published web-based programmes to improve 
PA for people with LTMCs. An internet-mediated study using pedometers to reduce 
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disability in people with chronic low back pain reported short-term (six months follow up), 
but not long term (one year follow up), improvements in comparison to enhanced usual 
care17. Poor adherence or declining engagement over time were demonstrated so there is a 
need for programmes to consider how to keep people active and engaged. 
 
This study aimed to explore the feasibility of delivering and evaluating a web-based walking 
intervention (“Walk30X5”) for people with LTMCs and to determine its acceptability to 
participants and the feasibility of conducting a definitive trial.  
The objectives were to:  
1. Evaluate the feasibility of achieving proposed recruitment rates (N=40). 
2. Evaluate recruitment and the flow of participants through the study, identifying rates 
and reasons for attrition and reporting adverse events. 
3. Evaluate the fidelity of intervention provision; that participants received their 
allocated treatment. 
4. Evaluate the adherence of participants to “Walk30X5”. 
5. Evaluate the performance and suitability of outcome measures for use in a definitive 
trial. 
6. Determine the sample size required for a definitive trial. 
Semi-structured interviews were carried out with physiotherapists providing the 
intervention and trial participants to explore the acceptability of the intervention; word 
count means these data will be presented separately and not included in this paper.  
 
METHODS 
Jo
urn
al 
Pre
-pr
oo
f
6 
 
Design.   A feasibility study and pilot trial at one NHS site.    
The Intervention.  
 “Walk150” (summarised in Table 1) was developed using an iterative consensus process, 
incorporating the opinions and input of patients with a variety of LTMCs (n=16) and clinical 
and research physiotherapists (n=15)18. A website was commissioned and eight podcasts 
were scripted (providing audio and musical tempi instructions) (name removed), revised 
(team) and produced (using a professional sound studio and actor). Podcasts are digital 
audio files that can be downloaded onto a mobile device such as a smart phone or MP3 
player. The podcasts were designed to assist people to begin and increase their amount of 
moderate-vigorous walking over time (Additional file 1). 
Participants: Adults referred for assessment and advice by GPs, physiotherapists or 
themselves for any mild /moderate/non-severe musculoskeletal conditions affecting PA (eg: 
chronic back pain, fibromyalgia, lower limb arthritis) with joint pain lasting at least 3 
months, and considered physically able (after screening) to undertake the programme. 
Participants were included if they reported < 120 mins of moderate intensity activity 
(4X30mins) per week and were able to perform the 6 minute timed walk test (own pace, no 
walking aid) with non-severe reports of pain (≤ 6/10 verbal rating scale). Exclusion criteria: a 
recent history of an illness likely to interfere with the ability to undertake the programme 
safely; serious cardiac or respiratory diagnoses; lower limb fractures (last 12 months); 
blindness; systemic illness; if they reported that a doctor had advised against exercise; or 
were pregnant or unable to participate in the intervention. Participants were not included if 
they were receiving current/additional physiotherapy. 
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Recruitment: Participants were approached via the Musculoskeletal Interface Service, 
outpatient physiotherapists and advertisements. Following telephone screening, 
participants attended a research appointment at the [Name removed to protect 
anonymity]. Informed consent was obtained and baseline assessment was performed by a 
research physiotherapist. Baseline assessments started with blood pressure checks and the 
timed 6 minute walk test, to check eligibility, followed by all outcomes if eligible (referred 
back for medical care if ineligible).  GPs were also sent a letter on the day of baseline 
assessment to allow them to veto participation. The recruitment target to explore the 
feasibility of “Walk30X5” and collect data to calculate sample size for a definitive trial19 was 
n=40. Randomisation was performed by a mathematician independent of the study using 
random number tables and transferred to a sequence of sealed, numbered, opaque 
envelopes used in strict consecutive order. Participants were randomised following baseline 
assessment.   
 
Participants were randomised to either usual care or “Walk30X5”. All interventions were 
provided by musculoskeletal physiotherapists trained in delivering the interventions by the 
research team. 
Usual care (UC) group protocol:  Usual physiotherapy advice and assessment session and 
one follow up session. In session one participants were asked about their PA levels and 
advised how they might become more active. Participants set a PA goal (e.g. go swimming 2-
3 times per week, walk, cycle) for review at follow up in 8 weeks time.   
“Walk30X5” group protocol: Session one included UC and an introduction to the 
intervention. Participants were shown the website and podcasts and practised how to use 
them. Participants not owning an MP3 player, or concerned about downloading podcasts, 
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were provided with an MP3 player with all podcasts installed and ready for immediate use. 
Any obvious barriers to doing the programme (e.g coping with inclement weather) were 
discussed and tips and a plan of action agreed. A follow up session was held at 8 weeks. 
Participants were asked to record their podcast use in a diary (dates used, which level of 
podcast, and whether it was done in one or two chunks each time) and encouraged to 
record their comments about their experience of “Walk30X5”. 
 
Assessments: Baseline, 3 months and 6 months assessments were held at an outpatient 
physiotherapy department by a research physiotherapist blinded to group allocation. At 
baseline assessment demographic data were obtained. At follow up assessments 
participants were asked to report adverse events, including falls20. People who did not 
attend for follow up were contacted by email or phone (participant preference) after their 
non attendance and, if no response contacted a further time two weeks later. 
 
Outcomes:  The proposed primary outcome for a definitive trial was the timed six minute 
walk test (T6MWT); an objective measure of aerobic capacity and long distance walking 
capacity recording the distance (m) covered in a 6-minute walking period over a 10 m 
walkway in a gymnasium. Participants were instructed to walk as briskly as possible and  
could pause/rest during the test if needed. T6MWT distance positively correlates with lower 
limb muscle strength, balance, reduced walking impairment and improved quality of life; it 
is sensitive to detect change following physical therapy interventions21. 
Secondary Outcomes:   
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Step count: Step count per day for 7 days after each assessment time point (using Omron 
HJ-720ITC pedometer22). The pedometer was set up for use and demonstrated by the 
research physiotherapist and written instructions provided. Usable data was defined a 
minimum of 5 full days data wear. 
Numeric Rating Scales (scores 0-10): uni-dimensional numerical rating scales (NRS) 
measured self-reported pain today and worst pain (intensity), average pain, and fatigue over 
7 days23-24.  
Positive and Negative Affect Schedule (PANAS)25: a self-report measure of mood, with two 
scales, positive and negative, each scored between 10-50. A higher score on the positive 
scale indicates more positive effect, a lower score on the negative score indicates less 
negative effect.  
The General Self-Efficacy Scale26: a self-report measure (score 10-40) of self-efficacy; the 
higher the score, the greater self-efficacy reported.   
Happiness: a single question from the short-form health survey (SF-36) with 6 responses 
varying from ‘all the time’ to ‘never’ which has good internal consistency with the other 4 
"mental health" scores and the 4 items from the "vitality" scale of the SF-3627. 
A self-report global health rating question28. 
The British Heart Foundation’s “Daily Activities Questionnaire” (DAQ): adapted from a 
validated American measure29 which measures the amount of self-reported PA during the 
previous 7 days. This measure asks participants to recall the frequency, duration and 
intensity of 48 physical activities covering: travel to work by cycle, or by walking; activity at 
work, at home (types of housework), in the garden, other activities around the home (types 
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of DIY), walking for leisure, outdoor cycling for leisure, stair climbing, sports and recreation 
plus a global physical activity question. 
The Axivity AX3 wrist worn accelerometer: to provide an indirect objective estimate of 
energy expenditure and measure of longitudinal movement data (total movement counts 
and average movement counts per hour). How to wear the accelerometer was 
demonstrated by the researcher and written instructions with photographs provided. The 
accelerometer was worn for 7 days after each assessment. Usable data was defined as a 
data file containing a minimum of 5 full days data wear. 
Blood Pressure (BP): measured using a GE Medical DINAMAP ® PRO 400 Vital Signs Monitor 
with a Critikon Dura-Cuf.  
Peak expiratory flow rate (PEFR), or peak expiratory flow (PEF): measured using a portable 
peak flow meter. The highest value from three attempts was recorded (l/min). 
Weight: measured in kilograms using calibrated SECA scales.  
A trial diary was kept by the research team, recording all written and verbal feedback from 
participants and physiotherapists during the trial regarding the interventions, outcomes and 
trial processes to provide additional acceptability information (to supplement the 
acceptability information provided from the interviews with physiotherapists and 
participants and checking of physiotherapy treatment notes to ensure participants received 
their allocated treatment).  
Data analyses: Data analyses were undertaken by the team and unblinded. Recruitment, 
retention numbers, baseline characteristics, adverse events, flow through the trial and trial 
process evaluations were described. Trial diary data, walking diary data, patient treatment 
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notes and compliance with interventions and outcomes were evaluated to explore 
acceptability and adherence: qualitative data underwent content analysis (CML, discussed 
and checked by team members). Treatment notes were checked to identify whether 
participants received their allocated intervention. Attendance, walking diary data and 
treatment note data were described to provide information on engagement and adherence.  
 Formal statistical hypothesis test results are inappropriate for feasibility trials. Instead the 
data were described and, where appropriate, group mean/median change scores for 
outcomes within the two groups were presented. An intention to treat approach was used. 
For accelerometer data, compliance was reported as the percentage of total wear-time 
recorded from that expected. The amount of useable data from accelerometers, and the 
extent to which data agreed with other measures, such as pedometer data, was explored; 
ordinary least-squares linear regression were used to derive the correlation (validity) 
coefficient together with the standard error of the estimate to test the association between 
higher counts per hour scores and higher self-reported scores for pedometer and DAQ.  
Sample size calculations were undertaken by a senior statistician independent to the study 
team.  
 
RESULTS 
Recruitment: All participants completed baseline assessments with no safety concerns; no 
GPs vetoed participation in the trial. 89 people were screened to participate and 41 
participants recruited. 21 participants did not meet the eligibility criteria, 13 did not reply, 8 
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participants were undergoing other physiotherapy, 3 were not interested, 1 did not want to 
travel for treatment, 1 did not have time to participate, and 1 had moved away.   
Flow through the study: Four participants withdrew due to medical reasons (2 emergency 
hospital admissions, one fracture and one ruptured tendon, all unrelated to the trial).  Four 
more participants did not reply to invitations to attend 6 month follow up assessments. 
There were no adverse events reported. Flow through the trial is presented in Figure 1.  
Intervention Fidelity: 36 (88%) sets of treatment notes were available (control n=19, 
“Walk30X5” n=17) to check whether participants had received their allocated treatment. 33 
(80%) participants attended both treatment sessions, 3 (7%) participants (control n= 1, 
“Walk30X5” n=2) attended the first session only. No protocol violations were reported, all 
participants received their allocated treatment. Participants spoke of the individualised, 
flexible progression of treatments. Participants’ comments suggested that the UC arm had 
gone beyond UC, becoming a new goal setting intervention in its own right. UC Participants 
spoke of the value of spending half an hour with a physiotherapist, discussing activity, the 
impact of individualised goal setting and the identification of strategies to increase PA. The 
importance of a follow up session upon implementing changes in activity was emphasized 
by participants. 
Adherence to podcasts: 13 (65%) walking diaries were returned from 20 “Walk30X5” 
participants. Participants were requested to complete 5 podcasts per week:  median 
number of podcasts reported was 4.88, mean adherence was 4.92 (range 3 – 7 per week). 
Acceptable adherence was defined for this study as participants doing at least 4 podcasts a 
week for at least 4 weeks; 11 (out of data from 12 diaries) participants exceeded this 
amount. Fewer podcasts were reported in week 1 by two participants who started the 
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programme midweek and diary completion lessened over time to n=10 in week 8 due to 
missing data and being on holiday (Supplementary file 2). Participants’ comments showed 
that people progressed through podcasts, repeating podcasts if they found them tough, and 
the majority did the podcasts in one go rather than splitting them into two chunks. 
Feedback confirmed that 135 bpm promoted fast walking without running. People 
mentioned missing podcasts due to illness, being away from home, undertaking non 
podcast walks and other PA such as swimming.  
Website: Participants were to be shown the website during their first session of 
physiotherapy and to have discussed the content with their physiotherapist and future use 
of the website was monitored. 7 participants reported looking again at the website near the 
start, but not later on, in the programme. 
Performance and suitability of outcome measures. 
Baseline characteristics are presented in Table 2: The groups were not statistically different 
for mean T6MWT at baseline (p=0.13). At six months the “Walk30X5” group mean T6MWT 
had improved by 97 m compared to 55m in UC (p=0.03). Groups were statistically different 
at baseline for mean step count (p=0.02); the “Walk30X5” group mean step count was 6543 
(SD 3227) and 4390 (SD 2267) for UC. At six months mean step count for the “Walk30X5” 
group had improved by 1720 steps and UC by 1555 steps.  Outcome data for outcomes 
considered acceptable to participants are presented in Table 3. Both groups reported 
improved worst pain ratings: the “Walk30X5” group mean rating improved by 2.02 and UC 
by 0.71. Both groups demonstrated mean weight loss from baseline to six months: 5 kg for 
the “Walk30X5” groups and 2 Kg for UC. The “Walk30X5” group, unlike UC, also reported 
improved NRS for pain today (mean improvement 0.75), average pain (mean improvement 
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1.7) fatigue scores (mean improvement 1.97) and both PANAS scales (mean improvement 
positive scale 2.78, mean improvement negative scale 2.32). 
DAQ: Qualitative data, trial diary comments and feedback from the research 
physiotherapists indicated that participants found the DAQ to be over lengthy. The majority 
of participants reported not doing the activities listed in the majority of domains or missed 
out questions.  Since so few data were obtained for the majority of domains they have not 
been statistically summarised and MET values were not calculated. 
Wrist worn accelerometers and pedometers:  Six participants reported irritation and/or 
discomfort whilst wearing accelerometers. Research physiotherapists reported that many 
more participants stated their dislike at the length of time they needed to wear 
accelerometers. This was reflected, in addition to software and technological problems, in 
the amount of useable returned data over time. Usable data required at least 5 days full use 
of the accelerometer and pedometer for the same worn dates for each participant.  
At baseline n=37/41 returned an accelerometer with retrievable data, n=33 met the wear-
time criteria of an average of >12 hours per day. Mean wear time was 23.5 hours per day 
(SD=7.6). At 3 months n=25 returned an accelerometer with retrievable data. N=23 met the 
wear-time criteria of an average of >12 hours per day. Only n=20 participants (49%) 
provided usable data at baseline and 3 months. At baseline there were n=33 valid 
accelerometer cases, n=37 valid pedometer cases and n=31 cases that had valid data from 
both measures. The positive correlation between Pedometer (mean daily steps) and 
Accelerometer (movement index) was strong (0.73). At three months there were n=23 valid 
accelerometer cases, n=33 valid pedometer cases and n=20 cases that had valid data from 
both measures. The positive correlation between Pedometer (mean daily steps) and 
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Accelerometer (movement index) was weak (0.27). It is of note that only 14 participants 
provided usable data for all time points which was insufficient to meaningfully analyse at 6 
months (unavailable data for n=27, 66%). 
Sample size for a future trial: To detect a difference of 100m in 6MWT at one year with 90% 
power at the 5% (2-sided) significance level, assuming a standard deviation of 100 (as 
observed at baseline) requires data on 23 people in each arm. Allowing for 20% loss to 
follow up, whilst striving for a follow up rate of at least 90%, the estimated sample size for a 
definitive trial is 58 participants, equivalent of detecting a moderate standardised effect size 
of 0.5. Calculation for 80% power requires 17 people in each arm (n=34, allowing for 20% 
drop out n=44).  
 
DISCUSSION 
This study achieved the aims of developing a physiotherapy walking programme 
intervention for use by people with mild/moderate LTMCs and exploring the acceptability of 
the intervention to patients and the feasibility of conducting a future definitive trial.   
Unlike many previous walking programme trials, “Walk30X5” is not condition specific but  
designed for general use by people with mild to moderate LTMCs and to be feasible for the 
NHS to implement should it prove an effective intervention. The study included participants 
with a wide variety of LTMCs, averaging 6-7 years duration and including people with 
multiple LTMCs (Table 2). All participants were able to participate and there were no 
adverse events reported. Adherence to “Walk30X5” was high and participants progressed 
through the podcasts as intended. Adherence to podcast walking was higher than the 50% 
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adherence level for typical web-based interventions promoting health and changes in health 
care behaviours30. Feedback from “Walk30X5” trial diaries indicated that participants were 
achieving moderate to vigorous activity. The taxomony techniques included to promote 
behavioural change appeared appropriate, particularly the beneficial effects of reviewing 
progress at follow-ups31. “Walk30X5” participants provided positive feedback about the 
website content and it being a well organised, easy to navigate, site. Website use tailed off 
over time and the majority of people did not engage repeatedly with the website, possibly 
because participants preferred to be provided with an MP3 player with all podcasts pre-
installed so they did not need to download further podcasts. Physiotherapists found some 
participants preferred to phone with queries as usual rather than log on and message them.  
Further research is thus required to ascertain the value of the website. The information 
architecture for the website was designed by users, implementing a sequential fashion to 
ensure optimal layout and navigation around the site32. No changes to “Walk30X5” are 
considered necessary for a main trial. The UC arm needs to be adapted to appropriately 
reflect usual UK practice since feedback from participants indicated that UC had gone 
beyond UC to become a new intervention.  
 
Recruitment, retention and trial procedures: The recruitment target was achieved. 
Although we report no exclusions at referral and baseline screening phases the number of 
medical withdrawals was higher than we expected given the age of participants. This may 
have been by chance or may reflect that many people with LTMCs also have multi-
morbidity. Four out of five people with osteoarthritis also have at least one other long term 
condition and more than three out of ten people aged over 45 years who report a long term 
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condition (such as cardiovascular disease) also have a LTMC33. In response, sample size 
calculations for a future RCT would allow for a 20% attrition rate, and multi-morbidity will 
be captured and reported. Trial procedures (randomisation, allocation concealment, blind 
outcome assessment, receiving the allocated treatment, flow) were shown to be feasible. 
 
Performance of outcomes: There were acceptability and performance issues with the DAQ 
and wrist worn accelerometers and their use is not recommended in a main trial. We 
propose to replace the DAQ with the validated 4-item Short International Physical Activity 
Questionnaire (IPAQ-SF)34 as a self-report measure of PA which contains far fewer items and 
less time to complete than the DAQ . The Musculoskeletal Health Questionnaire (MSK-HQ)35 
will also be included to capture PA participation among people with musculoskeletal 
conditions36. The Axivity accelerometers were not acceptable to participants and the 
amount of useable returned data over time prevented meaningful analysis. This differs from 
recent research of 103,712 Axivity UK Biobank datasets which reported a high median wear-
time (6.9 days) and acceptability to participants37. This difference may be due to the face-to-
face questioning during assessments about acclerometers in “Walk30X5”, compared to 
returning bands by post37,  plus a minority of Biobank participants (n=106,053, 49%) agreed 
to wear an accelerometer.  
 
No notable problems with other outcomes were identified. The feasibility study was not 
powered for hypothesis testing19 however the data presented in Table 3 are considered 
justification for a definitive trial.  Data for the primary outcome, T6MWT, are promising: 
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improving by an average of 97.46 meters for “Walk30X5” participants and 54.78 m for UC. 
Whilst these improvements are less than the estimated minimal clinically important 
difference for this test for people with fibromyalgia, reported as 156-167m38, these data 
were improving over time and the primary endpoint in a future trial would be at least a 
year. Further research is needed to determine Clinically Meaningful Change Estimates for 
this test among people with other LTMCs which would be explored in a main trial. It is 
believed that walking speed is an appropriate outcome for people with LTMCs.  Gait speed is 
positively associated with PA for people with hip and knee osteoarthritis, with evidence 
(limited by high heterogeneity across studies) that inactivity is a predictor for deterioration 
of pain and physical function39-41. Being less sedentary is related to better physical function 
in adults with knee osteoarthritis42. Slower walking speed is a risk factor for worsening 
depressing symptoms over time in people with/at high risk of knee osteoarthritis (OA)43 and 
anxiety-related responses to pain likewise correlate with gait speed for people with lower 
limb OA44. People with symptomatic knee OA have a higher risk of declining gait speed than 
those with asymptomatic OA45. Walking is also known to be compromised in people with 
chronic low back pain; pain intensity and distribution significantly impact upon walking 
speed and walking can have an analgesic effect46. Evidence suggests that middle-aged 
women with fibromyalgia have gaits and walking speeds similar to elderly women47. For 
older people, walking speed is a reliable, valid and responsive Sixth Vital sign: indicative of 
an individual’s general health status and functional capacity, and predictive for a range of 
outcomes48. Step count was also improving over time in both groups (Table 3). In addition to 
walking speed there were also promising changes observed for the“Walk30X5” group for 
pain, at six months median improvement for average and worst scores were equal to/above 
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the minimal clinically important difference of 2 points49, fatigue and weight loss but no 
between group comparisons can be made at this time. 
The limitations of this study, a single site study, with unblinded data analyses and lack of 
long term follow up, would be addressed in a main trial now that the feasibility of the 
intervention has been explored. It is acknowledged that the intervention was provided as 
part of a research study, it is possible that participants preferred to phone/email the study 
team directly rather than use the website to comment or raise queries and this may also 
have contributed to the low use of the website already discussed. The qualitative study 
exploring acceptability indicates the website content was acceptable, appropriate and 
understandable, the site easy to use by participants and no changes are required before a 
main trial.  
Conclusions: This research developed an innovative, web-based, podcast delivered, 
progressive cadence, walking programme designed to help inactive people with long term 
musculoskeletal conditions to increase their levels of physical activity in order to improve 
health. The promising findings support its acceptance to patients and the intervention is 
ready, subject to future funding, for investigation in a main trial to determine the 
effectiveness of “Walk30X5”. Should “Walk30X5” prove effective and cost effectiveness it is 
designed to be feasible for implementation within the NHS; to be added into routine 
physiotherapy care and/or, after additional testing, to possibly be added to the NHS website 
to be freely downloaded by people in the same way as the ‘Couch to 5k’ running 
programme. 
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Contribution of the Paper statement:  
 “Walk 30X5” is a new innovative walking programme intervention designed to help 
people with long term musculoskeletal conditions to improve their levels of physical 
activity and promote health. 
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 “Walk30X5” is a web-based intervention, which includes eight progressive digital 
audio podcasts, and was developed by people with long term musculoskeletal 
conditions, researchers and physiotherapy clinicians. 
 “Walk 30X5” is feasible, acceptable and ready for evaluation in a definitive trial. 
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Figure 1. Flow through the feasibility study 
  
Assessed for eligibility (n=89) 
Excluded (n=48) 
   Not meeting inclusion criteria (n=21 ) 
   Declined to participate (n=5) 
   Other reasons (n=22) 
Analysed (n=20) 
 
Lost to follow-up (give reasons) (n=5) 
Medical reasons unrelated to trial n=2 
Lost contact n=3 
 
 
 
Allocated to “Walk30X5” intervention (n=20) 
 Received allocated intervention (n=20) 
 
Lost to follow-up (give reasons) (n=3) 
Medical reasons unrelated to trial n=2 
Lost contact n=1 
 
 
Allocated to usual care intervention (n=21) 
 Received allocated intervention (n=21) 
 
Analysed (n=21) 
 
 
   Allocation 
    Analysis 
  Follow-Up 
Randomized (n=41) 
Enrollment 
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Table 1. A summary of the “Walk30X5” Intervention 
Component Content Techniques included in 
the intervention to 
promote behaviour 
change* 
 
Website:  A (non-public) 
secure website 
 
A home page, introduction, tips on getting 
ready, motivational information about physical 
activity, benefits of physical activity, the 
podcasts, coping with flare ups, how to 
continue being active after “Walk150” and links 
to other health and activity sites. Comments 
could be shared by users &/or the team 
contacted via the website.  
 
 
Goal Setting: to achieve 150” 
moderate/vigorous activity 
per week.  
 
Behaviour Action Planning: 
Discuss and actively plan how 
to achieve goal at session 1 
and how to maintain activity 
at session 2. 
 
Graded Tasks: Individualised 
progression (speed, time) 
through podcasts. 
 
Information about health 
consequences: from 
physiotherapist and website. 
 
Increasing knowledge:  from 
physiotherapist and website. 
 
Monitoring by 
physiotherapist: follow up 
session, walking diary data.  
 
Review of behavioural goals 
by physiotherapist: at follow 
up session. 
 
Self-monitoring: using a 
walking diary. 
 
Individualised, flexible 
intervention: discussed and 
agreed at session 1, flexible 
progression and modification 
by participant, discussed and 
agreed at session 2.  
 
8 Podcasts (PC): These 
build in intensity. 
Podcast one lasted 20 
minutes and podcast 
eight lasted 34 minutes. 
 
PCs started and ended with normal (usual pace) 
walking for warm up/cool down.  
Early PCs:  walking mostly at usual pace with 
short periods of moderate speed (instructed 
and encouraged on podcasts to “walk briskly 
enough for your heart rate to increase and your 
breathing to quicken, but you should still be 
able to have a conversation”). Final PC = 30 
mins moderate to vigorous walking.  
Musical tempi; the beats per minute used in 
background music supported walking speed 
and progressed through the podcasts: from 
below normal pace (105 bpm) and slow (115 
bpm) in early podcasts to tempo of 135 bpm for 
moderate/vigorous walking #  
 
People requested to do 5 PC/week, progressing 
at their own pace if/when ready (usually 8 
weeks). Progression was flexible and 
individualised by the participant: people started 
at PC 1. If too easy, they tried PC 2 on the next 
walk and progressed until they found the PC 
where perceived exertion matched the PC. 
They did this PC for 1week and assessed 
progress: if ready they progressed PC. If not, 
they repeated the same PC for a week and then 
re-assessed. Progress assessed weekly.  
Flexibility: Each PC could be done all in 1 walk 
or split into 2 halves (2 walks per day). People 
could  do several PC together (e.g. at 
weekends) if  preferred and symptoms 
permitted.  
 
* Michie et al 201331  #in accordance with advice from internationally acknowledged expert  (Prof Costas 
Karageorghis). 
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Table 2. Baseline characteristics of the “Walk30X5” and the Usual Care Groups. 
Characteristics at Baseline “Walk30X5” 
 
Usual Care 
Total number of participants 
randomised to each group 
20 21 
Gender: males 
              females 
5 
15 
3 
18 
Mean age in years (SD) 
 
54 (14) 61 (16) 
Mean height in cm (SD) 
 
164 (8) 
 
165 (17) 
 
Mean weight in in kg (SD) 
 
80 (23) 
 
78 (14) 
 
Presenting condition/s: 
Multiple/s 
Osteoarthritis 
Fibromyalgia 
Back pain + weakness 
Radiating back pain 
Spinal stenosis 
Tendinopathy 
Post Hip replacement 
Baker’s cyst 
Plantar fasciitis 
Undiagnosed 
 
5 
1 
2 
4 
3 
1 
0 
1 
1 
1 
1 
 
 
7 
3 
3 
2 
2 
2 
1 
0 
0 
0 
1 
Duration of condition in months: 
Median (IQR) 
81 
(63 to 93) 
75 
(66 to 89) 
Location of condition/s: 
Multiple sites 
Spine 
Hip 
Knee  
Ankle 
 
12 
3 
1 
2 
2 
 
15 
3 
1 
1 
1 
Occupation: 
In work 
Not in work 
Retired 
Full time carer 
Unknown 
 
10 
3 
5 
1 
1 
 
11 
2 
7 
0 
1 
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Table 3.  Outcome scores for the “Walk30X5” (WG) and Usual Care (UC) groups at 
baseline, 3 and 6 months.   
Outcome 
 
Baseline 
     WG                           UC  
3months 
    WG                            UC 
6 months 
     WG                             UC 
Mean T6MWT in m (SD) 
95% CI 
N= 
 
Median Step Count/Day  
(IQR) 
N= 
 
Median NRS Pain Today 
(IQR) 
N= 
 
Median NRS Worst Pain 
(IQR) 
N= 
 
Median NRS Average Pain 
(IQR) 
N= 
 
Median NRS Fatigue (IQR) 
N= 
 
Median PANAS positive 
(IQR) 
N= 
 
Mean PANAS negative 
(SD) 
95% CI 
 
Median GSES (IQR) 
N= 
 
Median Happiness (ISQ) 
N= 
 
Median GRS (IQR) 
N= 
 
Median weight (IQR) 
N= 
 
Mean Peak Flow (SD) 
95% CI 
N=  
 
Median Systolic BP (IQR) 
N= 
 
Median Diastolic BP (IQR) 
N= 
 
454.9 (99.5) 
408.3, 501.5 
(n=20) 
 
6887  
(3254 to 9390) 
(n=19) 
 
2.5 (1.6 to 4) 
(n=20) 
 
5.8 (3.6 to 8) 
(n=20) 
 
3.5 (2.3 to 5) 
(n=20) 
 
 
5.5 (3 to 7)* 
(n=20) 
 
31 (26 to 35)  
(n=19) 
 
15 (12 to 27)* 
(n=20) 
 
27 (28 to 30) 
(n=20) 
 
4 (4 to 4)* 
(n=20) 
 
3 (3 to 4)* 
(n=20) 
 
75 (66 to 89) 
(n=20) 
 
425 (131) 
363, 486 
(n=20) 
 
126 (116 to 
151) (n=20) 
 
79 (69 to 89) 
(n=20) 
407.5 (98.8) 
362.7, 452.2 
(n=21) 
 
3719  
(2722 to 5651) 
(n=19) 
 
2 (1 to 4) 
(n=21) 
 
6 (2.5 to 7.5)* 
(n=21) 
 
3 (1.8 to 4.5) 
(n=21) 
 
 
5 to (2 to 6.5)* 
(n=21) 
 
34 (28 to 38)  
(n=19) 
 
13 (11 to 20)* 
(n=20) 
 
30 (27 to 31) 
 
 
5 (4 to 5)* 
(n=21) 
 
3 (3 to 4) 
(N=21) 
 
81 (63 to 93) 
(n=21) 
 
353 (108) 
304, 402 
(n=21) 
 
127 (112 to 
138) 
 (n=21) 
 
79 (68 to 81)* 
 (n=21) 
503.9 (111.6) 
448.4, 559.4 
(n=18) 
 
7246 
(4338 to 
10547) 
(n=18) 
 
2* (0 to 5) 
(n=19) 
 
3 (2 to 8)* 
(n=19) 
 
3 (1 to 5) 
(n=19) 
 
 
3 (1.4 to 4) 
(n=19) 
 
33 (28 to 37) 
(n=19) 
 
14 (12 to 21)* 
(n=18) 
 
29 (29 to 31)* 
(n=19) 
 
4 (4 to 4)* 
(n=19) 
 
3 (2 to 4)* 
(n=19) 
 
73 (66 to 92)* 
(n=18) 
 
433 (139) 
364, 502 
(n-18) 
 
136 (118 to 
149) (n=18) 
 
79 (69 to 85) 
(n=18) 
438.4 (103.1) 
388.7, 488.1 
(n=19) 
 
4866 
(3024 to 
6520) 
(n=17) 
 
2 (1 to 3.5)* 
(n=19) 
 
5 (4 to 7) 
(n=19) 
 
3 (2 to 4) 
 (n=19) 
 
 
4 (2 to 5) 
(n=19) 
 
34 (33 to 37)* 
(n=19) 
 
13 (11 to 15)* 
(n=19) 
 
32 (29 to 35) 
(n=19) 
 
5 (4 to 5)* 
(n=19) 
 
3 (2 to 4)* 
(n=19) 
 
80 (67 to 91)* 
(n=19) 
 
368. (97.) 
322, 415 
(n=19) 
 
127 (112 to 
138) (n=18) 
 
74 (69 to 80) 
(n=18) 
552.4 (122.8) 
481.4, 559.4 
(n=14) 
 
8857  
(5565 to 
10532) 
(n=14) 
 
1 (0 to 3)* 
(n=15) 
 
3 (1 to 7) 
(n=15) 
 
1.5 (1 to 4)* 
(n=15) 
 
 
3 (1-4) 
(n=15) 
 
34 (27 to 39) 
(n=15) 
 
15 (12 to 27)* 
(n=15) 
 
30 (28-32) 
(n=15) 
 
4 (4 to 4)* 
(n=15) 
 
4 (2 to 4)* 
(n=15) 
 
70 (65 to 79)* 
(n=14) 
 
433 (123) 
362, 505 
(n=14) 
 
127 (119 to 
140) (n=14) 
 
74 (69 to 81) 
(n=14) 
462.3 (102.2) 
409.7, 514.9 
(n=17) 
 
4669* 
(3713 to 
8571) 
(n=15) 
 
2.5 (1 to 4.5) 
(n=17) 
 
4.6 (2.7 to 
6.8) 
(n=17) 
 
2 (1.2 to 5) 
(n=17) 
 
 
4 (1.5 to 6.8) 
(n=17) 
 
30 (27 to 35) 
(n=17) 
 
13 (11 to 20)* 
(n=17) 
 
31 (28 to 35) 
(n=17) 
 
5 (4 to 5)* 
(n=17) 
 
3 (2 to 4)* 
(n=17) 
 
78 (65 to 84)* 
(n=18) 
 
371 (100) 
321, 421  
(n=18) 
 
130 (114 to 
149) (n=18) 
 
77 (67 to 83) 
(n=18) 
* Data not normally distributed for this group at this timepoint 
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Additional File 1. An overview of the content of the eight “Walk150” podcasts  
 
Podcast 
Number  
Description of amounts of normal pace and brisk walking 
Total time 
Of podcast 
1 2 ½ minutes usual (normal) pace (105 bpm music). Then 60 seconds brisk walking 
(115 bpm music) followed by 90 seconds normal pace (105 bpm music) – repeated 6 
times. 2 ½ minutes normal pace (105 bpm music) 
20 minutes 
2 2 minutes usual pace (105 bpm music). Then 90 seconds brisk walking (115 bpm 
music) followed by 60 seconds normal pace (105 bpm music) followed by 3 minutes 
brisk walking (115bpm music) then 2 minutes normal walking (105 bpm): repeat this 
section 3 times 
24 and a half 
minutes 
3 2 minutes usual pace (progressed to 115 bpm music). Then 5 minutes brisk pace  
(progressed to 125 bpm music) followed by 2 minutes normal walking (115 bpm 
music: repeated 3 times.  
23 minutes 
4 2 minutes usual pace (115 bpm music) followed by 8 minutes brisk pace (125 bpm 
music) followed by 3 minutes of normal walking (115 bpm music) followed by 10 
minutes of brisk walking (125 bpm music) ending with 2 minutes usual walking (115 
bpm) 
25 minutes 
5 2 minutes usual pace (115 bpm music). Then 10 minutes brisk pace (125 bpm 
music) followed by 2 minutes of normal walking (115 bpm music) followed by 15 
minutes of brisk walking (125 bpm music) ending with 2 minutes usual walking (115 
bpm), 
31 minutes 
6 2 minutes normal walking (115 bpm music) followed by 20 minutes (125 bpm music) 
followed by 2 minutes normal walking (115 bpm music) followed by 8 minutes brisk 
walking (progressed to 135 bpm music), 2 minutes normal walking (115 bpm music) 
34 minutes 
7 2 minutes normal walking (115 bpm music), 25 minutes brisk walking (135 bpm 
music), 2 minutes normal walking (115 bpm music) 
29 minutes 
8 2 minutes normal walking (115 bpm music), 30 minutes brisk walking (135 bpm 
music), 2 minutes normal walking (115 bpm music) 
34 minutes 
 
